Abteilung Antebi
Molekulare Genetik des Alterns
Altern wird als eine allmähliche Abnahme der organismischen Homöostase und der physiologischen Funktionen definiert und ist mit einem erhöhten Risiko für altersbedingte Krankheiten verbunden. Das Antebi-Labor untersucht die Regulationsmechanismen, die diese Prozesse steuern
Wir verwenden den Fadenwurm C. elegans, den Killifisch Nothobranchius furzeri und menschliche Zellen zur Untersuchung des Alterns. Unsere Arbeit verbindet traditionelle genetische Ansätze mit der Systembiologie (Transkriptomik, Proteomik, Interaktomik und bildgebende Verfahren) und modernster metabolomischer und lipidomischer Profilierung von alterungsbedingten Prozessen.
[ mehr über unsere Forschung ]
Ausgewählte Publikationen
Decreased spliceosome fidelity and egl-8 intron retention inhibit mTORC1 signaling to promote longevity
Huang, W., Kew, C., Fernandes, SA., Löhrke, A., Han L., Demetriades, C. and Antebi, A.
(2022) Nature Aging 2, 796-808.
Regulation of the one carbon folate cycle as a shared metabolic signature of longevity
Annibal, A., Tharyan, R., G.Schonewolff, M. F., Tam, H., Latza, C., Auler, M. M. K., Gronke, S., Partridge, L., Antebi, A.
(2021) Nat Commun, 12, 1, 3486
HLH-30/TFEB Is a Master Regulator of Reproductive Quiescence
Gerisch, B., Tharyan, R. G., Mak, J., Denzel, S. I., Popkes-van Oepen, T., Henn, N., Antebi, A.
(2020) Dev Cell, 53, 3, 316-329 e5
Small nucleoli are a cellular hallmark of longevity
Tiku, V., Jain, C., Raz, Y., Nakamura, S., Heestand, B., Liu, W., Spath, M., Suchiman, H. E. D., Muller, R. U., Slagboom, P. E., Partridge, L., Antebi, A.
(2017) Nat Commun, 8, 16083
Hexosamine pathway metabolites enhance protein quality control and prolong life
Denzel, M. S., Storm, N. J., Gutschmidt, A.Baddi, R., Hinze, Y., Jarosch, E., Sommer, T., Hoppe, T., Antebi, A.
(2014) Cell, 156, 6, 1167-78
Drittmittel-
|
|
---|---|
2020 - 2025 |
ERC Advanced Grant
NuAge, Nucleolar regulation of longevity |
2020 - 2021 |
DAAD, Decoding Aging Initiative
in collaboration with Mori lab, Univ Campinas, Brazil |
2018 - 2025 | DFG/CECAD Cluster of Excellence Cellular Stress Responses in ageing-associated disease |
2009 - present |
Max Planck Society Core Funding
Toxic Protein Consortium |
Vergangene
|
|
---|---|
2018 - 2020 |
Max Planck Society
Lead development of small molecule activators of GFAT-1, in collaboration with Lead Discovery Center, Dortmund |
2015 - 2020 |
BMBF/EndoProtect
Prevention of neuronal protein aggregation through endogenous mechanisms |
2018 - 2019 |
DAAD
Decoding Aging Initiative, in collaboration with Mori lab, Univ Campinas, Brazil |
2013 - 2018 | DFG/Cluster of Excellence Cellular Stress Responses in ageing-associated disease |
2009 - 2013 | DFG/Cluster of Excellence Cellular Stress Responses in ageing-associated disease |
2017 |
Volkswagen Stiftung
support for GRC conference, Integrative Biology of Ageing |
2017 |
NIH
support for GRC conference, Integrative Biology of Ageing, co-applicant |
2010 - 2017 |
BMBF/GerontoSys
SyBACol Systems Biology of Aging, Cologne, Grant |
2011 - 2015 |
DFG/SFB635 project C9
Regulation of C. elegans developmental timing by the F-box protein DRE-1-FBXO11 |
2011 - 2014 |
Max Planck Excellence Funds
Toxic Protein Consortium |
2007 - 2011 |
Ellison Medical Foundation Senior Scholar in Aging
Nuclear complexes that regulate C. elegans life stages and aging |
2006 - 2011 |
NIH RO1
A lipophilic hormone pathway regulating development and aging |
2006 - 2010 |
NIH RO1
An E3 ubiquitin ligase complex that regulates C. elegans developmental timing |
2007 |
Debakey Excellence in Research Award
Baylor College of Medicine |
2005 - 2007 |
NIH Nuclear receptor signaling atlas (NURSA)
pilot and feasibility grant |
2005 - 2006 | Baylor Seed Fund Award |
2004 - 2006 |
BMBF National Genome Research Grant 2
on Aging, Germany |
2000 - 2003 |
European Community Grant
5th Framework, Agegen |